🇺🇸 FDA
Patent

US 11241394

Treating vasculature related diseases or disorders using nanoparticles

granted A61KA61K31/337A61K47/6901

Quick answer

US patent 11241394 (Treating vasculature related diseases or disorders using nanoparticles) held by The Regents of the University of California expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/337, A61K47/6901, A61K9/5153, A61K9/5169